WW International (WW) said Thursday it is now offering access to Eli Lilly's (LLY) newly FDA-approved oral GLP-1 medication, Foundayo, for weight loss through its Med+ program and affiliated medical groups.
The company said the addition of Foundayo gives eligible members a new once-daily, injection-free treatment option for weight loss.
Price: 945.99, Change: -7.31, Percent Change: -0.77
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments